Merck (MRK) Completes Acquisition of EyeBio

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. CMG
7. TENB
8. KLAC
9. BIIB
10. ETSY

Go back to Merck (MRK) Completes Acquisition of EyeBio

Merck Completes Acquisition of EyeBio

July 12, 2024 6:45 AM EDT

Acquisition strengthens and diversifies Mercks pipeline with the addition of Restoret, a novel late-phase candidate for diabetic macular edema and neovascular age-related macular degeneration, as well as preclinical candidates

RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of Eyebiotech Limited (EyeBio). EyeBio is now a wholly-owned subsidiary of Merck.

The EyeBio acquisition further diversifies our late-stage pipeline with the addition of a promising candidate based on novel biology and... More